Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AAN | its green grass for bnb mow my friends | 11/05/07 | 1 | 2.6K | |||
|
|||||||
AAN | i vote with bnb | 11/05/07 | 6 | 3.6K | |||
|
|||||||
AAN | opportunity | 11/05/07 | 2 | 3.3K | |||
|
|||||||
AAN | ruling | 03/05/07 | 0 | 690 | |||
|
|||||||
AAN | am i the only one | 03/04/07 | 8 | 3.7K | |||
|
|||||||
AAN | macquarie bid | 15:27 | 0 | 606 | |||
|
|||||||
AAN | not a good reaction | 11:09 | 1 | 751 | |||
|
|||||||
AAN | when does it trade | 10:17 | 1 | 644 | |||
|
See All Discussions